Filter
202
Text search:
counterfeit
Featured
Recommendations
13
New Publications
65
Language
Document type
No document type
108
Studies & Reports
39
Guidelines
27
Manuals
10
Strategic & Response Plan
8
Fact sheets
5
Situation Updates
3
Training Material
2
Countries / Regions
Uganda
11
Kenya
11
Nigeria
8
Ethiopia
7
Ghana
7
Liberia
6
Tanzania
6
Sierra Leone
5
Cambodia
5
Zambia
4
Malawi
4
Botswana
4
Myanmar / Burma
4
Zimbabwe
3
South Africa
3
Bangladesh
3
Eswatini/ Swaziland
3
South–East Asia Region
3
Global
3
Burkina Faso
2
Mali
2
Cameroon
2
Philippines
2
Rwanda
2
Namibia
2
Ukraine
2
Guinea
1
Senegal
1
Congo, Democratic Republic of
1
Haiti
1
India
1
Somalia
1
Nepal
1
Pakistan
1
Thailand
1
China
1
Indonesia
1
Mozambique
1
Benin
1
Central African Republic
1
Lesotho
1
Latin America and the Carribbean
1
Western and Central Europe
1
Asia
1
Africa
1
Laos
1
Moldova
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
97
Public Health
11
Clinical Guidelines
9
Pharmacy & Technologies
6
Key Resources
3
Women & Child Health
1
Toolboxes
Pharmacy
34
AMR
31
Mental Health
6
HIV
5
TB
5
Global Health Education
5
COVID-19
5
Rapid Response
3
Refugee
3
Conflict
2
Caregiver
2
Planetary Health
2
Disability
1
Ebola
1
Specific Hazards
1
Social Ethics
1
NCDs
1
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical device
...
These guidelines are aimed to provide guidance to Member States in developing their own national measures to combat counterfeiting of medicines. The guidelines include: an overview of the problems and factors concerning the counterfeiting of medicines; important steps to be followed in developing na
...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 37.
Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329.
The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this
...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant
...
This Medical Product Alert relates to the recent circulation of two confirmed falsified versions of Quinine
Sulphate circulating in Cameroon and the Democratic Republic of the Congo, containing zero active
pharmaceutical ingredient
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resistance and lead to loss of confidence in health prof
...
The prevalence, availability, and use of antimalarial medicines (AMLs) were studied in six Cambodian provinces along the Thai-Cambodian border. The study was divided into two parts: the first looked at the quality of AMLs available in Pursat, Pailin, Battambang, Bantey Meanchey, Oddar Meanchey, and
...
Working Document Nov. 2020
The COVAX Supply and Logistics workstream lead by UNICEF, Gavi and WHO have released a working copy of the COVID-19 Vaccination, Country Readiness & Delivery: Supply and Logistics Guidance. Countries might find this Guide useful when developing and strengthening their sup
...
Antimicrobial resistant (AMR) organisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for HIV and the pathogens that cause malaria, tuberculosis, typhoid, cholera, meningitis
...
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o
...
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provide for the registration and regulation of pharmacie
...
